Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Jun 15, 2019; 11(6): 489-498
Published online Jun 15, 2019. doi: 10.4251/wjgo.v11.i6.489
Published online Jun 15, 2019. doi: 10.4251/wjgo.v11.i6.489
Influencing factor | Proportional risk factor | 95%CI | P-value | |
Gender | M | 1 | ||
F | 1.312 | 0.771-2.223 | 0.316 | |
Age | ≤60 yr | 1 | ||
>60 yr | 1.819 | 1.032-3.207 | 0.038 | |
Bismuth-Corlett classification | II | 1 | ||
III | 2.633 | 0.992-6.984 | 0.052 | |
IV | 6.102 | 2.040-18.251 | 0.001 | |
Ways to reduce jaundice | Stenting | 1 | ||
Drainage | 0.263 | 0.134-0.516 | 0.000 | |
Comprehensive treatment | No | 1 | ||
Yes | 0.039 | 0.016-0.091 | 0.000 | |
CA19-9 | - | 1.002 | 0.999-1.004 | 0.147 |
- Citation: Zheng WH, Yu T, Luo YH, Wang Y, Liu YF, Hua XD, Lin J, Ma ZH, Ai FL, Wang TL. Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma. World J Gastrointest Oncol 2019; 11(6): 489-498
- URL: https://www.wjgnet.com/1948-5204/full/v11/i6/489.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i6.489